Cargando…
Real-life experience of ledipasvir and sofosbuvir for HCV infected Korean patients: a multicenter cohort study
BACKGROUND/AIMS: To evaluate the efficacy and safety of ledipasvir/sofosbuvir (LDV/SOF) therapy in hepatitis C virus (HCV)-infected Korean patients in a real clinical setting. METHODS: A total of 273 patients who received LDV/SOF therapy between May 2016 and February 2021 were consecutively enrolled...
Autores principales: | Lee, Soon Kyu, Lee, Sung Won, Lee, Hae Lim, Kim, Hee Yeon, Kim, Chang Wook, Song, Do Seon, Chang, U Im, Yang, Jin Mo, Yoo, Sun Hong, Kwon, Jung Hyun, Nam, Soon Woo, Kim, Seok-Hwan, Song, Myeong Jun, Lee, Jaejun, Yang, Hyun, Bae, Si Hyun, Han, Ji Won, Nam, Heechul, Sung, Pil Soo, Jang, Jeong Won, Choi, Jong Young, Yoon, Seung Kew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666263/ https://www.ncbi.nlm.nih.gov/pubmed/35618302 http://dx.doi.org/10.3904/kjim.2022.013 |
Ejemplares similares
-
A Real-World Comparative Analysis of Atezolizumab Plus Bevacizumab and Transarterial Chemoembolization Plus Radiotherapy in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis
por: Lee, Soon Kyu, et al.
Publicado: (2023) -
A Real-World Comparative Analysis of Lenvatinib and Sorafenib as a Salvage Therapy for Transarterial Treatments in Unresectable HCC
por: Lee, Jaejun, et al.
Publicado: (2020) -
Real-World Outcomes of Nivolumab in Patients With Unresectable Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus Infection
por: Sung, Pil Soo, et al.
Publicado: (2020) -
Safety and effectiveness of direct-acting antivirals in patients with chronic hepatitis C and chronic kidney disease
por: Ryu, Ji Eun, et al.
Publicado: (2022) -
Comparative Analysis of Lenvatinib and Hepatic Arterial Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multi-Center, Propensity Score Study
por: Lee, Jaejun, et al.
Publicado: (2021)